CHE Home
About
Why Study Chem, Bio & Pharm Engineering at NJIT?
Our People
Academics
Undergraduate Majors and Minors
Graduate Degree Programs
Research
Learning Beyond the Classroom
Info for Students
Careers in Chem, Bio & Pharm Engineering
News & Events
Contact Us
MS in Chemical Engineering
MS in Pharmaceutical Bioprocessing
MS in Pharmaceutical Engineering
PhD in Chemical Engineering
Certificate Programs
BS/MS Programs
Course Syllabi
Why Pharmaceutical Bioprocessing
New Jersey is considered a “hot bed” for pharmaceutical and bioscience companies, and has 32 public biotech companies that generated approximately $3.2 billion in revenue in 2007. This number represents a 113% increase from 2005. According to the Biopharmaceutical Industry Contributions of State and U.S. Economies published in 2004 by the Milken Institute, New Jersey’s biopharmaceutical industry created 264,600 jobs in the state.
Examples of major companies having major facilities in New Jersey abound. Johnson & Johnson, one of the world’s largest sources of biopharmaceutical medicines, is headquartered in Raritan, New Jersey. ImClone Systems Inc., which is global biopharmaceutical company committed to advancing oncology, has its headquarters in New York and its campus in Branchburg, New Jersey. Ortho Biotech Products, L.P., based in Bridgewater, N.J., is a leading biopharmaceutical company focusing on drugs to ease the lives of patients with cancer, anemia and kidney disease.
Based on the BioNJ 2008 Biotechnology Industry Survey, this trend is expected to continue: “New Jersey’s biotechnology industry will continue to demonstrate a significant level of growth and maturity well into the future.” The Pharmaceutical Bioprocessing program offers the opportunity to train the community for that future.
MS in Pharmaceutical Bioprocessing
New for fall 2009 (pending approval)
The focus of the MS Program in Pharmaceutical Bioprocessing (PhB) is to provide individuals with the knowledge needed to understand and apply sound engineering principles to the industrial production of therapeutics by means of biological processes. The use of microbial/biological systems and the manipulation of biological systems for the production of pharmaceutical products and therapeutic agents are becoming increasingly important for the health care industry as a whole. This program is designed to address the educational needs in this area, with its main emphasis placed on the engineering aspects of industrial bioprocessing. Students will be trained in areas such as microbial and cell growth operations, downstream recovery and bioseparation processes, bioprocess design, and validation and regulatory issues for biological production. Since this program is offered through the chemical engineering department and has strong ties to the pharmaceutical engineering program, the students will benefit from the use of basic chemical/pharmaceutical engineering approaches, such as transport phenomena and unit-operations principles, in order to understand and design bioprocesses for new biotherapeutics.
How can I learn more?
- Attend a graduate student open house
- Request information from our Graduate Admissions Office
- Contact program administrators professors Piero Armenante and Laurent Simon